SUMMARY Sera from 30 patients with inflammatory bowel disease (IBD) (16 with Crohn's disease (CD) and 14 with ulcerative colitis (UC)) were assayed for the presence of antibodies against 159 Escherichia coli 0-antigens and compared with sera from 16 matched control subjects. The majority of patients with IBD had agglutinating antibodies to a higher number of Escherichia coli 0-antigens and in higher titres than the control group. The number of positive agglutinins was 0-33 mean 13-8 in CD, 0-26 mean 7 9 for UC, and 0-7 mean 1 5 in controls. Eight patients with IBD and arthropathy had antibodies to fewer 0-antigens (0-7 mean 3-2). The antibodies were in the IgG and IgM, in titres corresponding to original values. No specific 0-serotypes were associated with IBD. Common serotypes, R-plasmid carrying serotypes, and those associated with shigella-like adult diarrhoea were detected. 014 was detected onlyin five patients and 01 l9in none. There was no correlation between the number of Escherichia coli agglutinins and the site and severity of the disease or type of therapy.
The involvement of immunological mechanisms in the pathogenesis of inflammatory bowel disease (IBD) has been extensively investigated (Goldgraber and Kirsner, 1958; Broberger and Perlmann, 1959; Perlmann et al., 1965; Wright and Truelove, 1966) . Broberger and Perlmann (1959) demonstrated the presence of an antibody in the sera of patients with ulcerative colitis which reacted with an antigen derived from human colon. The possibility that antigens derived from intestinal bacterial products may cause this immune stimulation led to the consideration that the intestinal flora may play a pathogenetic role, particularly Escherichia coli 014. Escherichia coli 014 was found to have a common antigen which reacted with human colonic mucosa (Perlmann etal., 1965; Lagercrantz etal., 1968) and autoantibodies to gut mucosa could be produced by injection of bacteria (Asherson and Holborow, 1966 (Perlmann et al., 1965; Thayer et al., 1969; Bull and Ignaczak, 1973) . Antigens derived from Escherichia coli 014 and another serotype, Escherichia coli 0119.K69 (B14) were also found to induce lymphocytes to become cytotoxic to colonic mucosa (Shorter et al., 1970; Bull and Ignaczak, 1973) . These findings led to the suggestion that these specific Escherichia coli serotypes are causally involved in the pathogenesis of inflammatory bowel disease.
In order to test this hypothesis, and because the intestinal Escherichia coli flora can contain a variety of serotypes over a period of time (Bettelheim et al., 1972; Shooter et al., 1977; Tabaqchali et al., 1977) , it was considered that an assay of antibodies to all currently accepted 159 Escherichia coli 0-antigens in the serum of patients with ulcerative colitis and Crohn's disease might give a better understanding of the bacterial role in these patients, and also determine if the antigenic stimulus is limited to the specific serotypes as previously reported, or if it is a widespread reaction.
Methods
Blood specimens were obtained from 30 patients 108 (Oxoid No. 3) for 18 hours, heating to 100°C in a water bath for one hour, and preserving with 0-05% formaldehyde on cooling. As controls, 0 sera raised in rabbits according to the methods of Ewing (1956-57) were employed.
All agglutination studies were performed in WHO trays. The patients sera were diluted to 1/100 (v/v) with 0-85 % aqueous sodium chloride (w/v) containing 1:10 000 thiomersalate (w/v) as preservative; 0-2 ml of each patient's diluted serum was tested against an equal volume of each Escherichia coli suspension. Each suspension was simultaneously tested against a similar dilution of specific rabbit antiserum as positive control and saline as a negative control.
The trays were examined visually for agglutination after 18 hours' incubation at 50°C. Agglutination was considered to have occurred when there was definite clumping at the bottom of the well, the supernatant solution was completely clear and, on tapping, the agglutinated clumps were visible. Control wells of saline mixed with 0 suspensions appeared uniformly turbid after similar treatment (Bettelheim, 1969) . A 'positive' test was taken as one giving a titre of 1/200. The antibody titres were determined by doubling dilutions on all positive reactions.
CHARACTERISATION OF IMMUNOGLOBULINS
Selected sera giving positive high titres were subjected to sucrose gradient ultracentrifugation and subdivided into six fractions using the method described by Desmyter et al. (1971) . Each of these fractions was titrated against some of the antigens previously found to give high titres. This method separates IgG and IgM fractions but IgA is not distinguishable. In a preliminary study with Escherichia coli 01 specific serum prepared in rabbits, it was found that the agglutinating antibodies were not affected by this treatment.
Results
The number of the different Escherichia coli serotypes to which antibody was present in the serum from each patient in the different disease groups is shown in the Figure. The majority of patients with inflammatory bowel disease had higher numbers of agglutinating antibodies to Escherichia coli than the control group. In each group there was a variation in the number of positive reactions, ranging from 0-33 in patients with Crohn's disease, 0-26 in patients with ulcerative colitis, and 0-7 in patients with inflammatory bowel disease and arthropathy and in control subjects. The frequencies of positive reactions were 13-8 per patient in Crohn's disease, 7-9 for ulcerative colitis, 3-2 for inflammatory bowel disease and arthropathy, and 1-56 in the control group. There was no correlation between the number of positive reactions and the site of the lesion in Crohn's disease or ulcerative colitis, the severity of the disease, or the type of therapy. The agglutinin titres found in the different groups of patients studied and the number of patients in whom these were present are shown in Table 2 . The titres ranged from 1:200 to 1:6400. The highest antibody titres against Escherichia coli 0-antigens were found in patients with Crohn's disease, and to a lesser extent in patients with ulcerative colitis. These high titres were distributed among several patients and not limited to a few. A greater number of patients with inflammatory bowel disease had higher titres than those with IBD and arthropathy or control subjects. The number of positive agglutination reactions to the common Escherichia coli 0 groups is shown in Table 3 . There were a substantial number of positive agglutination reactions to the common strains causing urinary tract infection and also to the common R factor strains. There were minimal reactions with the strains known to cause infantile diarrhoea. Only five patients and one control subject had positive reaction to 014 and none to 0119.
The agglutinating antibodies to the serotypes most (Cohen and Norins, 1968; Brown and Lee, 1973) , and in patients with inflammatory bowel disease (Perlmann et al., 1965; Lagercrantz et al., 1968; Thayer et al., 1969; Bull and Ignaczak, 1973; Brown and Lee, 1973) , the number of serotypes previously tested have always been very few. There are 159 internationally accepted Escherichia coli serotypes and these all provide specific 0-antigens based on the heat stable lipopolysaccharide of the cell wall of the bacterium. Various serotypes of Escherichia coli are present in different subjects and therefore, unless all the 0-antigens are tested, negative results may be reported. In order to avoid non-specific positive reactions, the agglutination tests were started at a dilution of 1:200.
The majority of patients with Crohn's disease and ulcerative colitis in this study had positive antibody reactions to a variety of Escherichia coli 0-antigens. The numbers and types of Escherichia coli 0-serotypes found were variable but there was no single serotype which was associated with the disease. Antibodies to commonly occurring 0 serotypes 01, 02, 018, and 075 were represented. These serotypes are generally considered to be commonly found in urinary tract infections and reflect the predominant 0-groups in the faecal flora. Antibodies to 08 and 09 antigens were also present; these 0-groups have been shown to be commonly associated with plasmid carrying resistance to antimicrobial agents (Hartley et al., 1975; Howe and Linton, 1976) (Table 3) . Escherichia coli 014 agglutinins were detected in only five patients and 0119 agglutinins were not present.
Previous emphasis on Escherichia coli 014 is due to the fact that this serotype is reported to possess on its surface, in an apparently more accessible site, an antigen present in nearly all Enterobacteriaceae, the enterobacterial common antigen of Kunin (Kunin et al., 1962 ). This has not been substantiated by our work since only five patients and one control subject had positive reactions against Escherichia coli 014.
As most strains of 014 currently available appeared partially antigenically degraded they will have many more serological cross-reactions, giving the impression of carrying a 'common' antigen. A really smooth 014 strain gives no more cross-reactions than many other E. coli 0 types in agglutination reactions performed as described in this paper, although other reactions may be observed if different serological methods such as haemagglutination are employed (Drach et al., 1972) . Care had to be taken to select a smooth colony for the preparation of the specific 014 antigen and the specific antisera in rabbits.
There were no reactions with Escherichia coli 0119 antigen in any of the sera tested, a finding similar to those of Thayer et al. (1969) who found 0119 antibody in only one out of 91 patients; but others have suggested higher incidences (Neter et al., 1955; Kunin and Beard, 1963) .
The antibody titres in patients with Crohn's disease and ulcerative colitis were higher than the control group, ranging from 1/400-1/6400. The high numbers of Escherichia coli antibodies and the high titres demonstrable in our patients may simply be due to an increase in the antigenic load entering the system through diseased or ulcerated bowel wall in sufficient quantity to overload the liver 'filter' system. Although the patients in this study had normal liver function and normal serum immunoglobulin levels, it is known that liver disease per se may be associated with increased number of antibodies to intestinal bacteria (Prytz et al., 1973; Simjee et al., 1975) .
Antibodies to Escherichia coli serotypes 0136, 0144, and 0124 were present in large numbers in our patients. It is of interest that OK types 0124: K72, 0136:K78, and 0144:K? (B) have been shown to be associated with adult diarrhoea, causing a colitis-like syndrome, and possess properties of invasiveness characteristic of virulent Shigella strains (Sakazaki et al., 1967; Ogawa et al., 1968) . It is possible that the antigenic stimulus and the degree of response may depend on the invasiveness of the organism. Whether invasive Escherichia coli strains play a role in the initiation of ulcerative colitis is uncertain at this stage and requires further elucidation.
In marked contrast to the general trend in inflammatory bowel disease, those patients whose disease was accompanied by an arthropathy had relatively low numbers of positive agglutinin reactions. One possibility is that in these patients, as well as in those with IBD and low agglutinins, the antibody present may be circulating in the form of immune complexes which are known to exist in such patients (Doe et al., 1973; Hodgson et al., 1977) . It is of interest to note that of three severely ill patients in whom no antibodies were detected, one had ankylosing spondylitis and another developed severe pyoderma gangrenosum.
The bacterial antibodies detected against the various Escherichia coli serotypes tested in this study were found in both the IgM and IgG fraction of the immunoglobulins and the titres corresponded to the initial values. The serum component in patients with Crohn's disease or ulcerative colitis that causes normal lymphocytes to become cytotoxic is thought to be a cytophilic IgM antibody (Shorter et al., 1971) and it is feasible that similar antibodies to a number of Escherichia coli serotypes could be involved in causing similar reactions.
The possibility of a pathogenetic relationship between these bacterial antigens and chronic inflammatory bowel disease is weakened by the finding of such a large number of Escherichia coli serotypes in this study. It is more likely that they are secondary to the disease process. However, there still remains the possibility that these bacterial antigens may play a role in the perpetuation of the disease process and in the extraintestinal complications associated with inflammatory bowel disease. 
